295 related articles for article (PubMed ID: 23249146)
1. Traffic jam at the blood-brain barrier promotes greater accumulation of Alzheimer's disease amyloid-β proteins in the cerebral vasculature.
Agyare EK; Leonard SR; Curran GL; Yu CC; Lowe VJ; Paravastu AK; Poduslo JF; Kandimalla KK
Mol Pharm; 2013 May; 10(5):1557-65. PubMed ID: 23249146
[TBL] [Abstract][Full Text] [Related]
2. Amyloid-Beta Peptides 40 and 42 Employ Distinct Molecular Pathways for Cell Entry and Intracellular Transit at the Blood-Brain Barrier Endothelium.
Wang Z; Sharda N; Omtri RS; Li L; Kandimalla KK
Mol Pharmacol; 2023 Nov; 104(5):203-213. PubMed ID: 37541759
[TBL] [Abstract][Full Text] [Related]
3. Alzheimer's amyloid β heterogeneous species differentially affect brain endothelial cell viability, blood-brain barrier integrity, and angiogenesis.
Parodi-Rullán R; Ghiso J; Cabrera E; Rostagno A; Fossati S
Aging Cell; 2020 Nov; 19(11):e13258. PubMed ID: 33155752
[TBL] [Abstract][Full Text] [Related]
4. Semimechanistic Population Pharmacokinetic Modeling to Investigate Amyloid Beta Trafficking and Accumulation at the BBB Endothelium.
Wang Z; Sharda N; Curran GL; Li L; Lowe VJ; Kandimalla KK
Mol Pharm; 2021 Nov; 18(11):4148-4161. PubMed ID: 34664956
[TBL] [Abstract][Full Text] [Related]
5. Beta-amyloid pathology in human brain microvessel extracts from the parietal cortex: relation with cerebral amyloid angiopathy and Alzheimer's disease.
Bourassa P; Tremblay C; Schneider JA; Bennett DA; Calon F
Acta Neuropathol; 2019 May; 137(5):801-823. PubMed ID: 30729296
[TBL] [Abstract][Full Text] [Related]
6. Anti-Parallel β-Hairpin Structure in Soluble Aβ Oligomers of Aβ40-Dutch and Aβ40-Iowa.
Fu Z; Van Nostrand WE; Smith SO
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33513738
[TBL] [Abstract][Full Text] [Related]
7. ABCG2 is upregulated in Alzheimer's brain with cerebral amyloid angiopathy and may act as a gatekeeper at the blood-brain barrier for Abeta(1-40) peptides.
Xiong H; Callaghan D; Jones A; Bai J; Rasquinha I; Smith C; Pei K; Walker D; Lue LF; Stanimirovic D; Zhang W
J Neurosci; 2009 Apr; 29(17):5463-75. PubMed ID: 19403814
[TBL] [Abstract][Full Text] [Related]
8. Distinct Uptake Kinetics of Alzheimer Disease Amyloid-
Sharda N; Ahlschwede KM; Curran GL; Lowe VJ; Kandimalla KK
J Pharmacol Exp Ther; 2021 Mar; 376(3):482-490. PubMed ID: 33303699
[TBL] [Abstract][Full Text] [Related]
9. Endothelial Mitochondrial Dysfunction in Cerebral Amyloid Angiopathy and Alzheimer's Disease.
Parodi-Rullán R; Sone JY; Fossati S
J Alzheimers Dis; 2019; 72(4):1019-1039. PubMed ID: 31306129
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of familial cerebral amyloid angiopathy mutant amyloid beta-protein fibril assembly by myelin basic protein.
Hoos MD; Ahmed M; Smith SO; Van Nostrand WE
J Biol Chem; 2007 Mar; 282(13):9952-9961. PubMed ID: 17259179
[TBL] [Abstract][Full Text] [Related]
11. Homocysteine potentiates amyloid
Carey A; Parodi-Rullan R; Vazquez-Torres R; Canepa E; Fossati S
Aging Cell; 2024 May; 23(5):e14106. PubMed ID: 38358083
[TBL] [Abstract][Full Text] [Related]
12. Anti-malaria drug artesunate prevents development of amyloid-β pathology in mice by upregulating PICALM at the blood-brain barrier.
Kisler K; Sagare AP; Lazic D; Bazzi S; Lawson E; Hsu CJ; Wang Y; Ramanathan A; Nelson AR; Zhao Z; Zlokovic BV
Mol Neurodegener; 2023 Jan; 18(1):7. PubMed ID: 36707892
[TBL] [Abstract][Full Text] [Related]
13. Origins of Beta Amyloid Differ Between Vascular Amyloid Deposition and Parenchymal Amyloid Plaques in the Spinal Cord of a Mouse Model of Alzheimer's Disease.
Yuan Q; Liu X; Xian YF; Tang Y; Zou J; Zhang X; Huang P; Wu W; Song YQ; Lin ZX
Mol Neurobiol; 2020 Jan; 57(1):278-289. PubMed ID: 31325023
[TBL] [Abstract][Full Text] [Related]
14. Cerebral amyloid angiopathy-linked β-amyloid mutations promote cerebral fibrin deposits via increased binding affinity for fibrinogen.
Cajamarca SA; Norris EH; van der Weerd L; Strickland S; Ahn HJ
Proc Natl Acad Sci U S A; 2020 Jun; 117(25):14482-14492. PubMed ID: 32518112
[TBL] [Abstract][Full Text] [Related]
15. Differences in amyloid-β clearance across mouse and human blood-brain barrier models: kinetic analysis and mechanistic modeling.
Qosa H; Abuasal BS; Romero IA; Weksler B; Couraud PO; Keller JN; Kaddoumi A
Neuropharmacology; 2014 Apr; 79():668-78. PubMed ID: 24467845
[TBL] [Abstract][Full Text] [Related]
16. Insights into Cerebral Amyloid Angiopathy Type 1 and Type 2 from Comparisons of the Fibrillar Assembly and Stability of the Aβ40-Iowa and Aβ40-Dutch Peptides.
Rajpoot J; Crooks EJ; Irizarry BA; Amundson A; Van Nostrand WE; Smith SO
Biochemistry; 2022 Jun; 61(12):1181-1198. PubMed ID: 35666749
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of ADAM10 promotes the clearance of Aβ across the BBB by reducing LRP1 ectodomain shedding.
Shackleton B; Crawford F; Bachmeier C
Fluids Barriers CNS; 2016 Aug; 13(1):14. PubMed ID: 27503326
[TBL] [Abstract][Full Text] [Related]
18. Cerebral Amyloid Angiopathy and Blood-Brain Barrier Dysfunction.
Gireud-Goss M; Mack AF; McCullough LD; Urayama A
Neuroscientist; 2021 Dec; 27(6):668-684. PubMed ID: 33238806
[TBL] [Abstract][Full Text] [Related]
19. Cationic carrier peptide enhances cerebrovascular targeting of nanoparticles in Alzheimer's disease brain.
Ahlschwede KM; Curran GL; Rosenberg JT; Grant SC; Sarkar G; Jenkins RB; Ramakrishnan S; Poduslo JF; Kandimalla KK
Nanomedicine; 2019 Feb; 16():258-266. PubMed ID: 30300748
[TBL] [Abstract][Full Text] [Related]
20. Pathogenic effects of cerebral amyloid angiopathy mutations in the amyloid beta-protein precursor.
Van Nostrand WE; Melchor JP; Romanov G; Zeigler K; Davis J
Ann N Y Acad Sci; 2002 Nov; 977():258-65. PubMed ID: 12480759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
